Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 403 citing articles:

Severe covid-19 pneumonia: pathogenesis and clinical management
Amy Attaway, Rachel G. Scheraga, Adarsh Bhimraj, et al.
BMJ (2021), pp. n436-n436
Open Access | Times Cited: 363
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
Franz X. Heinz, Karin Stiasny
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 339
Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence
Sayeeda Rahman, Maria Teresa Villagomez Montero, Kherie Rowe, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 5, pp. 601-621
Open Access | Times Cited: 250
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Daniel Martínez-Flores, Jesús Zepeda–Cervantes, Adolfo Cruz-Reséndiz, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 211
SARS-CoV-2 spreads through cell-to-cell transmission
Cong Zeng, John P. Evans, Tiffany King, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 119, Iss. 1
Open Access | Times Cited: 203
SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation
David W. Sanders, Chanelle C. Jumper, Paul J. Ackerman, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 191
Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission
Alba Escalera, Ana S. González-Reiche, Sadaf Aslam, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 3, pp. 373-387.e7
Open Access | Times Cited: 174
SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
Maaran Michael Rajah, Mathieu Hubert, Elodie Bishop, et al.
The EMBO Journal (2021) Vol. 40, Iss. 24
Open Access | Times Cited: 170
The glycosylation in SARS-CoV-2 and its receptor ACE2
Yanqiu Gong, Suideng Qin, Lunzhi Dai, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 166
SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19
Lize M. Grobbelaar, Chantelle Venter, Maré Vlok, et al.
Bioscience Reports (2021) Vol. 41, Iss. 8
Open Access | Times Cited: 156
Cell entry by SARS-CoV-2
Ruchao Peng, Lian-Ao Wu, Qingling Wang, et al.
Trends in Biochemical Sciences (2021) Vol. 46, Iss. 10, pp. 848-860
Open Access | Times Cited: 149
Aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2: Nanoscale electrode-aptamer-SARS-CoV-2 imaging by photo-induced force microscopy
J.C. Abrego-Martínez, Maziar Jafari, Siham Chergui, et al.
Biosensors and Bioelectronics (2021) Vol. 195, pp. 113595-113595
Open Access | Times Cited: 129
The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines
Mehrdad Mohammadi, Mohammad Shayestehpour, Hamed Mirzaei
The Brazilian Journal of Infectious Diseases (2021) Vol. 25, Iss. 4, pp. 101606-101606
Open Access | Times Cited: 125
The emerging SARS-CoV-2 variants of concern
Adekunle Sanyaolu, Chuku Okorie, Aleksandra Marinkovic, et al.
Therapeutic Advances in Infectious Disease (2021) Vol. 8
Open Access | Times Cited: 118
A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection
Guillaume Beaudoin-Bussières, Yaozong Chen, Irfan Ullah, et al.
Cell Reports (2022) Vol. 38, Iss. 7, pp. 110368-110368
Open Access | Times Cited: 114
The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern
Hikmet Akkız
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 82
SARS-CoV-2 and the Host Cell: A Tale of Interactions
Massimo Pizzato, Chiara Baraldi, Giulia Boscato Sopetto, et al.
Frontiers in Virology (2022) Vol. 1
Open Access | Times Cited: 69
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
Vivek P. Chavda, Rajashri Bezbaruah, Disha Valu, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 432-432
Open Access | Times Cited: 49
SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia
Olumayokun A. Olajide, Victoria U. Iwuanyanwu, Oyinkansola D. Adegbola, et al.
Molecular Neurobiology (2021) Vol. 59, Iss. 1, pp. 445-458
Open Access | Times Cited: 89
Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry
Selvin Noé Palacios-Rápalo, Luis Adrián De Jesús‐González, Carlos Daniel Cordero‐Rivera, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 88
Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
Zaixing Jia, Wenping Gong
Journal of Korean Medical Science (2021) Vol. 36, Iss. 18
Open Access | Times Cited: 87
SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
Ahmed M. Almehdi, Ghalia Khoder, Aminah Alchakee, et al.
Infection (2021) Vol. 49, Iss. 5, pp. 855-876
Open Access | Times Cited: 86
Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir
Qi Peng, Ruchao Peng, Bin Yuan, et al.
The Innovation (2021) Vol. 2, Iss. 1, pp. 100080-100080
Open Access | Times Cited: 79
Comparative Perturbation-Based Modeling of the SARS-CoV-2 Spike Protein Binding with Host Receptor and Neutralizing Antibodies: Structurally Adaptable Allosteric Communication Hotspots Define Spike Sites Targeted by Global Circulating Mutations
Gennady M. Verkhivker, Steve Agajanian, Deniz Yazar Oztas, et al.
Biochemistry (2021) Vol. 60, Iss. 19, pp. 1459-1484
Open Access | Times Cited: 77
Extracellular vesicles carry SARS‐CoV‐2 spike protein and serve as decoys for neutralizing antibodies
Zach Troyer, Najwa Alhusaini, Caroline O. Tabler, et al.
Journal of Extracellular Vesicles (2021) Vol. 10, Iss. 8
Open Access | Times Cited: 76
Page 1 - Next Page

Scroll to top